Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for L-Citrulline.
L-Citrulline acts as a potent endogenous precursor to L-arginine, facilitating the urea cycle and enhancing nitric oxide-mediated vasodilation to improve hemodynamic performance and reduce muscular fatigue.
9750
175.19 g/mol
-4.3
(2S)-2-amino-5-(carbamoylamino)pentanoic acid
Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for L-Citrulline across standard consumer modalities.
The high hygroscopicity of L-Citrulline requires moisture-resistant HPMC capsules and desiccant inclusion to prevent clumping and degradation.
Achieving therapeutic dosages in a gummy format is physically challenging due to the high active-to-excipient ratio required, which compromises structural integrity and texture.
The significant payload requirement for L-Citrulline far exceeds the typical 50-100mg capacity of thin-film oral strips, making this delivery method impractical for clinical efficacy.
Ready to launch a product featuring L-Citrulline? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.
Build Science-Backed FormulationNeed absolute proof that your L-Citrulline extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.
Simulate BioavailabilityIs your L-Citrulline payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.
Model Active Degradation